PCI in 6 is brought to you by Terumo Interventional Systems focusing on the ability to discharged patients. within 6 hours post PCI procedures.
Zhiroff, Transradial Intervention Does Not Compromise Technical Success
Khatri JJ, Case Report: Complex PCI
Sizemore BC, The Utility of a Universal Guide Catheter in STEMI with Multiple Culprit Lesions
RX ONLY. Refer to the product labels and package insert for complete warnings, precautions, potential complications, and instructions for use.
The Angio-Seal Vascular Closure Device product family, including the VIP and Evolution platforms, is indicated for use in closing and reducing time to hemostasis of the femoral arterial puncture site in patients who have undergone diagnostic angiography procedures or interventional procedures using an 8 French or smaller procedural sheath for the 8 F Angio-Seal device and a 6 French or smaller procedural sheath for the 6 F Angio-Seal device. The Angio-Seal VIP and Evolution platform devices are also indicated for use to allow patients who have undergone diagnostic angiography to safely ambulate as soon as possible after sheath removal and device placement, as well as to allow patients who have undergone an interventional procedure to safely ambulate after sheath removal and device placement.
Important Safety Information
Possible adverse events for vascular closure devices include, but are not limited to: bleeding or hematoma, AV fistula or pseudoaneurysm, infection, allergic reaction, foreign body reaction, inflammation or edema. This device should only be used by a licensed physician (or other health care professional authorized by or under the direction of such physician) possessing adequate instruction in the use of the device, e.g., participation in an Angio-Seal physician instruction program or equivalent.